FDA approves first neurotrophic keratitis drug
- Posted on: Aug 24 2018
- Leave a response
Following a priority review, the FDA has cleared cenergermin (Oxervate), a first-in-class treatment for moderate or severe neurotrophic keratitis.
Source: AAO
Posted in: Uncategorized
